x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001080
| Product Information | |
|---|---|
| Product Name | Human CKM ELISA Kit |
| Species | Human |
| Description | Human CKM ELISA Kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of CKM protein in cit plasma, edta plasma, hep plasma, serum, tissue extracts, and urine. It uses our proprietary ELISA technology. Quantitate Human CKM with 18.9 pg/mL sensitivity ELISA technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our ELISA plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. |
| Sample Types | Urine, Serum, Tissue Extracts, Hep Plasma, Edta Plasma, Cit Plasma |
| Detection Range | 62.5 pg/mL - 4000 pg/mL |
| Sensitivity | 18.9 pg/mL |
| Precision | CV: < 10% |
| Target Information | |
|---|---|
| Target Name | CKM |
| UniProt No. | P06732 |
| Gene ID | 1158 |
| Target Description | Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens. Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa. |
| Alternative Names | CKM; CKMM; Creatine kinase M; Creatine kinase M chain; Creatine kinase M type; Creatine kinase M-type; Creatine kinase muscle; Creatine kinase, muscle type; KCRM_HUMAN; M-CK; MCK; Muscle creatine kinase |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
